Abstract

Objectives: This study explored the effects of CGM treatment on malignant melanoma cells, specifically by focusing on its ability to induce apoptosis and alter the expression of proteins involved in epithelial-mesenchymal transition (EMT), a critical process in cancer metastasis. Methods: To assess cell viability and proliferation rates, at MTT assay and colony formation assay were performed. FACS analysis was conducted to confirm cell apoptosis, and JC-1 fluorescent staining was executed. An invasion assay was performed to observe cell invasiveness, and protein expression was validated by western blot analysis. Results: Our findings demonstrated that CGM treatment significantly induced apoptosis in malignant melanoma cells. Additionally, CGM treatment markedly reduced the invasiveness of melanoma cells, as observed in the invasion assays. Western blot analysis revealed that CGM modulated the expression of several critical proteins involved in EMT, thereby disrupting the EMT process which is essential for cancer metastasis. Conclusions: The research findings indicate that CGM inhibits the growth of melanoma effectively induces apoptosis of cancer cells, and suppresses metastasis through EMT inhibition. Therefore, CGM demonstrates significant value as a potential cancer therapeutic agent.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.